$CCXI News

Churchill Capital Corp XI Announces the Separate Trading of its Class A Ordinary Shares and Warrants, Commencing February 9, 2026

ChemoCentryx shares are trading higher after the company, and Amgen, announced an agreement under which Amgen will acquire the company for $52 per share in cash.

ChemoCentryx Upgraded To Strong Buy At Raymond James, Raises Price Target From $62 To $107; Says Regulatory Risk Is Removed, Says Thinks Tavneos Approval Will Be Blockbuster

ChemoCentryx Shares Tick Higher On Volume As Traders Circulate Upgrade To Strong Buy From Analyst At Raymond James

Why ChemoCentryx (CCXI) Stock Might be a Great Pick

ChemoCentryx, Inc. Just Reported Full-Year Earnings And Analysts Are Lifting Their Estimates

Edited Transcript of CCXI earnings conference call or presentation 10-Mar-20 9:00pm GMT

ChemoCentryx (CCXI) Reports Q4 Loss, Tops Revenue Estimates

ChemoCentryx Reports Fourth Quarter and Full Year 2019 Financial Results and Recent Highlights

ChemoCentryx, Inc. to Host Earnings Call

ChemoCentryx to Hold Fourth Quarter and Full Year 2019 Financial Results Conference Call on Tuesday, March 10, 2020

ChemoCentryx (CCXI) Expected to Beat Earnings Estimates: Should You Buy?

ChemoCentryx to Present at the 9th Annual SVB Leerink Global Healthcare Conference

Did The Underlying Business Drive ChemoCentryx's (NASDAQ:CCXI) Lovely 423% Share Price Gain?

ChemoCentryx to Present at the 38th Annual JP Morgan Healthcare Conference

Hedge Funds Dropped The Ball On ChemoCentryx Inc (CCXI)

The Week Ahead In Biotech: ASH 2019 Gets Underway, Biogen's Aducanumab Data And More

The Zacks Analyst Blog Highlights: Intercept, CymaBay, Amgen, Global Blood Therapeutics and ChemoCentryx

ChemoCentryx (CCXI) Upgraded to Buy: What Does It Mean for the Stock?

Company News For Nov 27, 2019